Support for Graduate, PDF and New Faculty Presenters at the 2022 American Society of Pharmacognosy Meeting

为 2022 年美国生药学会会议上的研究生、PDF 和新教师演讲者提供支持

基本信息

  • 批准号:
    10469168
  • 负责人:
  • 金额:
    $ 3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Natural products have provided humankind the key starting materials to support health by providing therapeutic agents and structural templates for medicinal chemists. The field of natural products is rapidly evolving to fill anticipated supply gaps due to the movement away from petroleum based energy, fine chemicals and pharmaceuticals. Although only about 1% of every barrel of oil is used in the manufacture of pharmaceutical products it is estimated petroleum supplies 99% of the starting materials for pharmaceutical and other consumer products. Thus one of three key Aims of this meeting includes the replacement of petroleum based starting materials for therapeutics with natural products. A second key aim for this meeting is an assessment of panomics approaches to the discovery and development of natural product prototypes for the control of cancer and emerging infectious diseases, including SARS-CoV2. Emerging methods involving CryoEM in drug discovery and development will be featured at this meeting. The need for better controls for emerging infectious diseases needs no explanation; however; the role of natural products as critical starting materials and new prototypes will be addressed as part of the 2022 American Society of Pharmacognosy Conference. Finally, a third key aim of the program is to assess the role that natural products and natural products investigators can play in controlling carbon dioxide levels in the environment. This can take the form of photosynthesis of agriculture or direct conversion of CO2 into the starting materials for pharmaceuticals and other consumer products. We fully anticipate that NPs will serve the needs of human health in regard to new prototypes well into the future. This conference will showcase many aspects of these emerging needs with cutting-edge approaches that are moving the field forward at an accelerated pace. We have selected leaders in the field as conference chairs and speakers that align well with the mission of the NCCIH including a significant number of speakers with expertise in analytical techniques for evaluating and standardizing materials used as complementary medicines. This project seeks funding to support the American Society of Pharmacognosy (ASP) meeting that will be held July 23-28th in Charleston, SC. The ASP is the largest society in the USA that focuses on natural products. The ASP as well as this conference focuses on molecules from nature and their application to improve human health. Support from the NIH will help offset registration fees and assist with travel for students and new faculty from the US and US Territories with a focus on regional HBCUs (historically black colleges and universities) of the South Eastern US. Thus our final aim is to train the next generation of scientists through the recruitment and support attendees from the PUIs with a focus on the Southeastern US.
项目总结/摘要 天然产品为人类提供了关键的起始材料,通过提供治疗, 药剂和结构模板。天然产品领域正在迅速发展, 由于石油能源、精细化学品和 大药厂尽管每桶石油中只有约1%用于制药 据估计,石油为制药和其他消费品提供了99%的起始原料。 产品.因此,本次会议的三个主要目标之一包括取代石油为基础的启动 天然产物的治疗材料。这次会议的第二个关键目标是对泛经济学进行评估 发现和开发用于控制癌症的天然产品原型的方法, 新出现的传染病,包括SARS-CoV 2。CryoEM在药物发现中的新兴方法 和发展将在这次会议上。需要更好地控制新出现的传染病 不需要解释;然而;天然产物作为关键起始材料和新原型的作用将 作为2022年美国生药学学会会议的一部分。最后,第三个关键目标是 该计划旨在评估天然产品和天然产品调查人员在控制 环境中的二氧化碳含量。这可以采取农业光合作用的形式, 将二氧化碳转化为药品和其他消费品的原材料。我们完全 预计纳米粒子将在未来很长一段时间内为人类健康的新原型需求服务。这 会议将展示这些新兴需求的许多方面,并采用先进的方法, 场地以更快的速度向前推进。我们选择了该领域的领导者作为会议主席和发言人 这符合NCCIH的使命,包括大量具有以下专业知识的演讲者 用于评估和标准化用作补充药物的材料的分析技术。这个项目 寻求资金支持将于7月23日至28日举行的美国生药学学会(ASP)会议 ASP是美国最大的专注于天然产品的协会。ASP也 因为这次会议的重点是来自自然界的分子及其在改善人类健康方面的应用。支持 美国国立卫生研究院的资金将帮助抵消注册费,并帮助来自美国的学生和新教师旅行, 美国领土,重点是东南部的区域HBCU(历史上的黑人学院和大学) 我们因此,我们的最终目标是通过招募和支持与会者来培养下一代科学家 重点关注美国东南部地区。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark T Hamann其他文献

Mark T Hamann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark T Hamann', 18)}}的其他基金

Synthesis and Optimization of the Aleutianamine Class of Alkaloids
阿留申胺类生物碱的合成与优化
  • 批准号:
    10799135
  • 财政年份:
    2022
  • 资助金额:
    $ 3万
  • 项目类别:
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
阿留申胺类生物碱的合成与优化
  • 批准号:
    10345968
  • 财政年份:
    2022
  • 资助金额:
    $ 3万
  • 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
  • 批准号:
    8707979
  • 财政年份:
    2012
  • 资助金额:
    $ 3万
  • 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
  • 批准号:
    8912993
  • 财政年份:
    2012
  • 资助金额:
    $ 3万
  • 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
  • 批准号:
    8541704
  • 财政年份:
    2012
  • 资助金额:
    $ 3万
  • 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
  • 批准号:
    8339007
  • 财政年份:
    2012
  • 资助金额:
    $ 3万
  • 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
  • 批准号:
    9230277
  • 财政年份:
    2012
  • 资助金额:
    $ 3万
  • 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
  • 批准号:
    9127149
  • 财政年份:
    2012
  • 资助金额:
    $ 3万
  • 项目类别:
MARINE CYSTINE KNOT PEPTIDES
海洋胱氨酸结肽
  • 批准号:
    8361215
  • 财政年份:
    2011
  • 资助金额:
    $ 3万
  • 项目类别:
CHEMISTRY CORE
化学核心
  • 批准号:
    8167941
  • 财政年份:
    2010
  • 资助金额:
    $ 3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了